SEC Form 4 · accession 0001437749-16-032595
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David G Kalergis
Officer — Chairman and CEO · Director
Period of report
May 16, 2016
Accepted (ET)
May 20, 2016 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.96 | May 16, 2016 | A | 204,167 | A | — | May 16, 2026 | Common Stock | 204,167 | 204,167 | D |
Explanation of responses
- F1The shares underlying the options vest in equal parts each month until fully vested on the third anniversary of the grant date.